Founded in 2010, Cell Guidance Systems (CellGS) develops technologies that support the delivery and application of bioactive molecules in research, biomanufacturing and therapeutic development. Its expertise focuses on controlling cell behaviour and cell fate through advanced protein delivery systems, biomaterials and cell culture technologies. The company's proprietary PODS® platform enables sustained and localized protein delivery, helping researchers investigate growth factor biology and therapeutic mechanisms. CellGS also develops PeptiGel® self-assembling peptide hydrogels for three-dimensional cell culture, supporting studies in stem cell biology, tissue engineering, regenerative medicine and disease modelling. Researchers additionally use its technologies in extracellular vesicle and exosome research workflows.
CellGS 'portfolio also includes growth factors, stem cell research reagents, primary cells and products for extracellular vesicle purification, analysis and characterization. They also provide genomic integrity testing services, including karyotyping and array genomic hybridization, together with custom protein production and exosome-related services. These tools and services support applications spanning cell culture, regenerative medicine, translational research, bioprocessing and therapeutic development.
Europa Biosite subsidiaries distribute for Cell Guidance Systems in Austria, Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden, Switzerland and the United Kingdom.
